Skip to the page

Data / Form D filings / Pandora Bio, Inc.

Pandora Bio, Inc.: Form D filings

Pandora Bio, Inc., a technology company in Sunnyvale, CA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on January 2, 2025, reports $410,000 sold of a $1 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1669 HOLLENBECK AVE #199, Sunnyvale, CA, 94087
Phone
(408) 828-2997
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1952211

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 2, 2025Amendment$1,000,000$410,000$590,00018May 17, 2023sec.gov
May 17, 2023New notice$1,000,000$55,000$945,0003May 17, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Megan RothneyExecutive Officer, Director
Tara MaddalaExecutive Officer, Director
Jason CarlsonDirector

Other technology companies in California that filed recently

Every Form D from the week of Dec 30, 2024 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Pandora Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.